
Functional magnetic resonance imaging
1990 · technique that maps brain activity through blood flow
Functional magnetic resonance imaging (fMRI) shows which regions of the brain become active while a person performs a task. It rests on a relationship known for more than a century: when a brain region works harder, blood flow to it increases. Before this technique existed, clinicians had very limited ways of linking a specific function to a specific area of the brain. Knowledge came mostly from injuries, animal studies or invasive procedures that could involve surgery, injections or radioactive substances.
Conventional magnetic resonance already produced anatomical images without ionizing radiation, but it showed only a static picture of brain structure. The idea behind the functional version was to extend the tool so that it could capture changes caused by neuronal activity. The link is provided by magnetic differences between oxygen-rich and oxygen-poor blood. Oxygenated hemoglobin is diamagnetic, while deoxygenated hemoglobin, which has released its oxygen to the tissues, is paramagnetic and alters the signal the scanner records. Linus Pauling and Charles Coryell had described these magnetic differences in 1936, although their relevance for brain imaging took decades to be exploited.
In 1990 Seiji Ogawa and his colleagues at AT&T Bell Labs described the blood-oxygen-level dependent (BOLD) contrast. They worked with rodents in a strong magnetic field and found that changes in oxygen levels were visible in the images. They then showed that these changes related to functional brain activity recorded with electroencephalography. In the following years, teams at Harvard, including the group led by Belliveau, and Kenneth Kwong and colleagues in 1992 demonstrated the method in humans, first in the visual cortex. The technique was not accepted without reservations: researchers had to show that the signals were reliable and not artifacts, and the early work was debated.
Today functional MRI is the dominant tool in brain mapping research because it requires no injections or radiation. Its spatial precision is within millimeters, although in routine use its temporal resolution is only a few seconds. In clinical practice it is used mainly to locate critical functions before surgery on a brain tumor, so that surgeons can remove as much of the lesion as possible while sparing language or hand movement. It is also used to study drugs and to assess awareness in patients with minimally responsive states.
Key dates
- 1890 Charles Roy and Charles Sherrington first link brain function to its blood flow.
- 1936 Linus Pauling and Charles Coryell describe the different magnetic properties of oxygenated and deoxygenated blood.
- 1990 Seiji Ogawa and colleagues describe the BOLD contrast in rodents.
- 1992 Three studies apply the BOLD contrast in humans for the first time.
- 1998 The default mode network, active during resting brain states, is described.
Key figures: Seiji Ogawa
Curiosities and anecdotes
A forgotten precursor
Angelo Mosso, in the late 19th century, devised a 'human circulation balance' meant to measure how blood is redistributed during emotional and intellectual activity. His work remained little known until the original instrument was rediscovered.
A controversial early use
According to the source, some companies have developed lie detectors based on fMRI, although the research is not considered mature enough for widespread commercial use.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.